Indiva Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Indiva şirketinin toplam hissedar öz sermayesi CA$-1.3M ve toplam borcu CA$21.7M olup, bu da borç-öz sermaye oranını -1692.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$37.8M ve CA$39.1M dir.

Anahtar bilgiler

-1,692.6%

Borç/özkaynak oranı

CA$21.69m

Borç

Faiz karşılama oranı	n/a
Nakit	CA$2.98m
Eşitlik	-CA$1.28m
Toplam yükümlülükler	CA$39.10m
Toplam varlıklar	CA$37.81m

Son finansal sağlık güncellemeleri

Recent updates

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

May 28

Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Sep 29

Is Indiva (CVE:NDVA) Using Debt In A Risky Way?

Sep 17

Is Indiva (CVE:NDVA) A Risky Investment?

Apr 19

Is Indiva (CVE:NDVA) Using Too Much Debt?

Feb 26

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Sep 04

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Nov 30

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NDVA.H negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: NDVA.H şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NDVA.H negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: NDVA.H 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: NDVA.H şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: Serbest nakit akışı her yıl % 22.6 oranında tarihsel oranda büyümeye devam ederse NDVA.H un bir yıldan az nakit akışı süresi vardır.

Indiva Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Indiva (CVE:NDVA) Using Debt In A Risky Way?

Is Indiva (CVE:NDVA) A Risky Investment?

Is Indiva (CVE:NDVA) Using Too Much Debt?

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Recent updates

Insufficient new directors

Indiva Limited Announces Resignation of Rachel Goldman from the Board

New major risk - Financial position

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024

Indiva Limited to Report Q1, 2024 Results on May 23, 2024

Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

New major risk - Negative shareholders equity

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Indiva Limited to Report Q4, 2023 Results on Apr 25, 2024

New major risk - Market cap size

Insufficient new directors

Indiva Limited announced that it expects to receive CAD 4.312 million in funding

Indiva Limited announced that it expects to receive CAD 4 million in funding

Price target increased by 15% to CA$0.15

Indiva Limited Provides Revenue Guidance for Fourth Quarter of 2023

Third quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.018 loss in 3Q 2022)

Indiva Limited to Report Q3, 2023 Results on Nov 21, 2023

Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Is Indiva (CVE:NDVA) Using Debt In A Risky Way?

Second quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.017 loss in 2Q 2022)

Indiva Limited to Report Q2, 2023 Results on Aug 29, 2023

Indiva Limited Launches No Future Gummies and Vapes

New minor risk - Shareholder dilution

New major risk - Share price stability

Indiva Limited announced that it expects to receive CAD 2.155617 million in funding from Canopy Growth Corporation

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2023

Indiva Limited, Annual General Meeting, Jul 18, 2023

Indiva Limited to Report Q1, 2023 Results on May 16, 2023

Is Indiva (CVE:NDVA) A Risky Investment?

Full year 2022 earnings: EPS and revenues miss analyst expectations

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$0.50

Indiva Limited to Report Q3, 2022 Results on Nov 22, 2022

Indiva Limited Provides Revenue Guidance for the Second Half and Full Year of 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Indiva Limited to Report Q2, 2022 Results on Aug 16, 2022

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022

Consensus estimates of losses per share improve by 62%

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022

Indiva Limited to Report Q1, 2022 Results on May 19, 2022

Price target decreased to CA$0.60

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Indiva Limited Provides Net Revenue Guidance for the First Quarter of 2022

Indiva Limited, Annual General Meeting, Jun 23, 2022

Indiva Limited to Report Fiscal Year 2021 Results on Apr 26, 2022

Is Indiva (CVE:NDVA) Using Too Much Debt?

Indiva Limited Launches New Cannabis Edible Designed for MicroDosing

Indiva Launches New Cannabis Edible Formulated for Night-Time Use

Third quarter 2021 earnings released: CA$0.047 loss per share (vs CA$0.035 loss in 3Q 2020)

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.029 loss in 2Q 2020)

Indiva Limited Provides Revenue Guidance for the Second Half of 2021

First quarter 2021 earnings released: CA$0.025 loss per share (vs CA$0.029 loss in 1Q 2020)

Full year 2020 earnings released: CA$0.16 loss per share (vs CA$0.14 loss in FY 2019)

Indiva Limited to Introduce Two New Bhang Chocolate Flavours Nationally in Second Quarter of 2021

Indiva Limited Ships Wana Quick Gummies

Indiva Limited Appoints Russell Wilson to the Board of Directors

Indiva Limited announced that it has received CAD 11 million in funding from Sundial Growers Inc.

Indiva Announces Extension to License Agreement with Wana Brands Inc

Indiva Limited announced that it expects to receive CAD 11 million in funding from Sundial Growers Inc.

New 90-day high: CA$0.49

New 90-day high: CA$0.28

Independent Director recently bought CA$65k worth of stock

Indiva Limited Promotes Rob Carse to Chief Operating Officer

Price target raised to CA$0.63

Analysts increase revenue estimates to CA$14.9m

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Third quarter 2020 earnings released: CA$0.035 loss per share

New 90-day low: CA$0.21